The overlap between leptin and FMD, especially as it relates to cardiovascular-related functional pathways, supports the substantial, potentially direct role that leptin may play in endothelial dysfunction and subsequent cardiometabolic pathology. This evidence concerns the gene LEP and endothelial dysfunction.